In the global market for endoscopes, the German-based Karl Storz company occupies a pivotal position. Its technology has not only led the development of the industry, but related products have also maintained a high market share in the world.
Since it settled in Pudong in 2006, Karl Storz has further accelerated its pace in the Chinese market. On the morning of December 9, the company's largest investment project in the Asia-Pacific region, the China headquarters building, which was built at a cost of 265 million yuan, was completed and opened in Zhangjiang Science City, and its China headquarters was also established at the same time.
As the inventor and pioneer of endoscopes, Karl Storz was founded in Tuttlingen, Germany in 1945 and has a history of 75 years. Its endoscope products cover the three major application fields of human medicine, animal medicine, and industrial endoscopes, with more than 15,000 types and more than 200 patents. As a global company, Karl Storz has extensive business operations all over the world. At present, the company has established more than 50 branches in more than 40 countries and regions on five continents.
In February 2006, Karl Storz established a subsidiary-Karl Storz Endoscopy (Shanghai) Co., Ltd. in Pudong. Facing the rapid development of the Chinese medical market and the continuous improvement of the business environment, Karl Storz is full of confidence in the Chinese market. This time, he spent 265 million yuan to build a new headquarters in China, which became its largest investment project in the Asia-Pacific region.
The building has a total construction area of more than 10,000 square meters and consists of two 4-story buildings. The building not only fully considers the needs of administrative offices, but also has other refreshing functional facilities, such as a historical wall showing the development of the company, a product exhibition hall that represents the forefront of the development of endoscopes, a well-equipped simulated hospital and training center, and Spacious and orderly working space for purchasing, logistics, and after-sales maintenance.
After years of development, Karl Storz has realized a whole-body, complete endoscope product system, and related products have penetrated into different fields of Chinese medical treatment. According to the latest survey data of the Chinese Society of Medical Engineering, only in the field of rigid endoscopes, the company has accounted for 46% of the national medical institutions, ranking first.
Now, combined with Karl Storz's product system, the company has launched a minimally invasive integrated operating room solution. “We start with the core surgical equipment of the enterprise and move from products to solutions, aiming to provide hospitals with more complete solutions.” Yang Mei, managing director of Karl Storz China, said: “In doing so, we hope to assist surgery It is more effective and safer, and the operation process is smoother. At the same time, it helps doctors achieve the best results in data collection and collection during and after the operation."